KSGO International Conference 2026 | The 4st Annual Meeting of Korean Society of Gynecologic Oncology | April 3(Fri) - 4(Sat), 2026 COEX MAGOK, Seoul, Korea

Scientific Program

검색
Clear Search
Program
April 3 (Fri)
12:50-13:30
E-poster Session - Line 1
Exhibition
Chair(s)

Gun Oh Chong (Kyungpook National University)

12:50-12:56 Clinical outcomes of pembrolizumab therapy in cervical adenocarcinoma according to HPV association: A single-institution retrospective study
Seongyun Lim (Sungkyunkwan University)
12:56-12:58 Floor Discussion
12:58-13:04 Cost-utility analysis of HPV–Pap co-testing for cervical cancer screening in Korea
Ju-Hyun Kim (Asan Medical Center)
13:04-13:06 Floor Discussion
13:06-13:12 Optimizing outcomes in minimally invasive radical hysterectomy: The protective role of a vaginal pipe
Seongmin Kim (Korea University)
13:12-13:14 Floor Discussion
13:14-13:20 Retrospective analysis of dose and efficacy of different applicators guided by CT imaging in large-volume cervical cancer brachytherapy
Na Zhang (Chongqing University Cancer Hospital)
13:20-13:22 Floor Discussion
13:22-13:28 Multidisciplinary diagnosis and treatment strategies for pregnancy complicated with cervical cancer
Qiuhong Li (The First Affiliated Hospital of Soochow University)
13:28-13:30 Floor Discussion
Program
April 3 (Fri)
12:50-13:30
E-poster Session - Line 2
Exhibition
Chair(s)

Sang Hun Lee (University of Ulsan)

12:50-12:56 Immune-inflammatory checkpoint pathways driving cervical precancer progression: A transcriptomic analysis
Tapatra Thanupran (King Mongkut's Institute of Technology Ladkrabang)
12:56-12:58 Floor Discussion
12:58-13:04 Trends in cervical cancer incidence by histopathologic type: An age-period-cohort analysis of an asian population from 1983-2022
Ann-Chi Shyur (Fu-Jen Catholic University Hospital)
13:04-13:06 Floor Discussion
13:06-13:12 A novel approach to opening the ureteral tunnel in type C radical hysterectomy: Anatomy of the Z-space
Jing Wang (Chongqing University Cancer Hospital)
13:12-13:14 Floor Discussion
13:14-13:20 SCOPE (smartphone colposcopy evaluation): A feasibility study of smartphone-based cervical cancer screening in the Kingdom of Eswatini
Eun Taeg Kim (Kosin University)
13:20-13:22 Floor Discussion
13:22-13:28 To evaluate the ability of a six‑gene DNA methylation assay to predict pathological upgrading or downgrading of cervical intraepithelial neoplasia (CIN) prior to loop electrosurgical excision procedure (LEEP)
Ying Jia (Chongqing Medical University)
13:28-13:30 Floor Discussion
Program
April 3 (Fri)
12:50-13:30
E-poster Session - Line 3
Exhibition
Chair(s)

Banghyun Lee (Inha University)

12:50-12:56 Recent antibiotic exposure reshapes longitudinal gut microbiome dynamics and predicts immunotherapy outcomes in gynecologic cancer
Hyun-Jin Choi (Chung-Ang University)
12:56-12:58 Floor Discussion
12:58-13:04 Pembrolizumab in patients with chemo-resistant gestational trophoblastic neoplasia: single arm, phase II trial (KGOG 2024/CR-GTP)
Yaesol Kim (Asan Medical Center)
13:04-13:06 Floor Discussion
13:06-13:12 Assessing the relationship between malnutrition and postoperative complications in gynecologic oncology
Chainarong Sillapasa (Chulalongkorn University)
13:12-13:14 Floor Discussion
13:14-13:20 Pretreatment CONUT score as a predictor of surgical outcomes and postoperative complications in ovarian cancer
Bhawna Arora (AIIMS)
13:20-13:22 Floor Discussion
13:22-13:28 Protective effect of GnRH agonists against chemotherapy-induced ovarian insufficiency in young patients with malignant ovarian germ cell tumors: A multicenter prospective study (KGOG 3048)
Yaesol Kim (Asan Medical Center)
13:28-13:30 Floor Discussion
Program
April 3 (Fri)
12:50-13:30
E-poster Session - Line 4
Exhibition
Chair(s)

Sang Hoon Kwon (Keimyung University)

12:50-12:56 Secondary cytoreductive surgery after chemotherapy for recurrent epithelial ovarian cancer (KOV-02S): a phase II randomized controlled trial
Ji Hyun Kim (National Cancer Center)
12:56-12:58 Floor Discussion
12:58-13:04 Evaluating alternative protocols for preventing cisplatin-induced AKI during HIPEC in ovarian cancer
Jimin Lee (Ajou University)
13:04-13:06 Floor Discussion
13:06-13:12 Updates on prospective phase III trial of standard of care therapy with/without SABR for recurrent ovarian cancer (SABR-ROC, KGOG 3064/KROG 2204)
Won Hee Lee (Korean Radiation Oncology Group)
13:12-13:14 Floor Discussion
13:14-13:20 Prognostic model for ovarian clear cell carcinoma using machine learning algorithms based on the SEER database
Tumarisi Tuniyazi (Dalian University of Technology)
13:20-13:22 Floor Discussion
13:22-13:28 A phase II study of AK112, a novel PD-1/VEGF bispecific antibody, combined with chemotherapy in platinum-resistant recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
Zhen Yuan (Peking Union Medical College Hospital)
13:28-13:30 Floor Discussion
Program
April 3 (Fri)
12:50-13:30
E-poster Session - Line 5
Exhibition
Chair(s)

Jinhwa Hong (Korea University)

12:50-12:56 Cost-utility analysis of maintenance treatment with olaparib for BRCA-mutated advanced epithelial ovarian cancer in Thailand
Jirapat Chanratchakool (Chulalongkorn University)
12:56-12:58 Floor Discussion
12:58-13:04 M2 macrophages drive chemoresistance in the ovarian cancer tumor microenvironment
Jae Sung Ryu (Soonchunhyang University)
13:04-13:06 Floor Discussion
13:06-13:12 Transcriptomic analysis of zonula occludens-1 (ZO-1) knockout in ovarian cancer cell lines
Hyung Joon Yoon (Pusan National University)
13:12-13:14 Floor Discussion
13:14-13:20 Treatment outcomes of LEEP in women with precancerous cervical lesions in Mongolia
Batzul Lkhagvasuren (National Center for Maternal and Child Health)
13:20-13:22 Floor Discussion
13:22-13:28 Diagnostic performance and concordance of CDO1 and CELF4 methylation in self-collected versus physician-collected samples for endometrial cancer detection
Feixue Xu (The First Hospital of Lanzhou University)
13:28-13:30 Floor Discussion
Program
April 3 (Fri)
12:50-13:30
E-poster Session - Line 6
Exhibition
Chair(s)

Yongil Ji (Inje University)

12:50-12:56 The influence of tumor extent and surgical-related factors on prognosis of intravascular leiomyomatosis(IVL)
Xiao Ma (Peking Union Medical College Hospital)
12:56-12:58 Floor Discussion
12:58-13:04 Development of a bio-plasma–based intrauterine device for targeted treatment of endometrial cancer
Soyoung Kim (Kyung Hee University)
13:04-13:06 Floor Discussion
13:06-13:12 Oncologic outcomes after incidental endometrial cancer diagnosis at hysteroscopy: A propensity score–matched comparison with dilation and curettage
Bo Ra Kim (Ewha Womans University)
13:12-13:14 Floor Discussion
13:14-13:20 Impact of the COVID-19 pandemic on gynecologic surgical case-mix: A six-year interrupted time series
Syamel Muhammad (Andalas University)
13:20-13:22 Floor Discussion
13:22-13:28 Pelvic floor reconstruction theory-based sexual rehabilitation nursing intervention for gynecological cancer survivors: A randomized controlled trial
Yao Yin (Chongqing Dianjiang County Hospital)
13:28-13:30 Floor Discussion
Program
April 3 (Fri)
08:30-17:00
E-Poster Exhibition
Exhibition
08:30-17:00 Retroperitoneal adenocarcinoma after prior oophorectomy: A genomic diagnostic case
Minfan Hsieh (Chiema Hospital)
08:30-17:00 Malignant brenner tumor with incomplete primary staging: Diagnostic ambiguities, surgical controversies, and oncologic implications—a case-based analysis
Hanifan Nugraha (Padjadjaran University)
08:30-17:00 Sclerosing stromal tumor of the ovary in a perimenopausal woman: A rare case report
Soyoung Park (Dong-A University)
08:30-17:00 Metabolic-secretory dissociation in recurrent ovarian cancer: Loss of CA-125 production despite maintained glucose hypermetabolism – a case series
Jung Mi Byun (Inje University)
08:30-17:00 Integrative genomic and clinicopathologic characterization of pure primary ovarian large cell neuroendocrine carcinoma
Ji Eun Choi (The Catholic University of Korea)
08:30-17:00 A case of rapidly growing primary ovarian leiomyosarcoma masquerading as uterine leiomyosarcoma: A diagnostic challenge
Hyung Joon Yoon (Pusan National University)
08:30-17:00 Clinical and genetic predictive factors of PARP inhibitor efficacy in advanced or recurrent ovarian cancer
In Sun Hwang (The Catholic University of Korea)
08:30-17:00 AI-assessed CT body composition and chemotherapy tolerance in ovarian cancer
Pei Ying Wu (National Cheng Kung University Hospital)
08:30-17:00 Increasing ovarian cancer incidence in Taiwan: A population-based age–period–cohort study, 1979–2023
Yuan-Ru Zhou (Fu Jen Catholic University Hospital)
08:30-17:00 Anti-B and T lymphocyte attenuator (BTLA) can be a potential target of immunotherapy in epithelial ovarian cancer (EOC)
Chia-Ying Wu (National Taiwan University Hospital)
08:30-17:00 Lactic acid alters γδ T cell levels and drives differential TCR expression in ovarian cancer, linked to poorer outcomes
Wen-Hsuan Lin (Mackay Memorial Hospital)
08:30-17:00 Concordance of genomic alterations in ovarian cancer tissues and circulating-tumor dna: A pilot study
Seongmin Kim (Korea University)
08:30-17:00 Cancer-associated thrombosis in epithelial ovarian cancer: Incidence, biomarker dynamics, and the role of tissue factor
Yu-Fang Huang (National Cheng Kung University Hospital)
08:30-17:00 Prognostic nutritional index (PNI) and its correlation in ovarian cancer survival - a single center experience
Anindhita Agus Setiawan (Persahabatan Hospital)
08:30-17:00 KMT2C and KMT2D regulate homologous recombination repair in epithelial ovarian cancer
Mirielle Ma (Yale University School of Medicine)
08:30-17:00 Oncologic and fertility outcome in patients with pure ovarian immature teratoma and gliomatosis peritonei: A single center experience
Pengrui Tang (Peking Union Medical College Hospital)
08:30-17:00 Real-world comparative effectiveness and toxicity of first-line PARP inhibitor maintenance in high-grade serous ovarian carcinoma (HGSOC)
Hyunji Lim (Seoul National University)
08:30-17:00 Impact of relative dose intensity of neoadjuvant chemotherapy on treatment efficacy and occurrence of platinum resistance in epithelial ovarian cancer: A multicenter retrospective cohort study
Tumarisi Tuniyazi (Dalian University of Technology)
08:30-17:00 Analysis of the association between genomic genetic variation spectrum and clinical outcomes in low-grade serous ovarian carcinoma
Qianfen Liu (Chongqing Medical University)
08:30-17:00 Peritoneal dissemination patterns in brca-mutated epithelial ovarian cancer: A clinicopathological study
Muthiah Muchlis (Hasanuddin University)
08:30-17:00 Adjuvant potential of perioperative NSAIDs after primary cytoreductive surgery for ovarian cancer: A Korean national registry analysis
Seongyun Lim (Sungkyunkwan University)
08:30-17:00 Establishing the prognostic value of iron-sulfur cluster assembly enzyme ISCU in epithelial ovarian cancer using bioinformatics techniques
Tian Hua (Xingtai People's Hospital)
08:30-17:00 To analyze the expression and significance of eukaryotic translation initiation factor 4e family member 3 in epithelial ovarian cancer based on bioinformatics technology
Tian Hua (Xingtai People's Hospital)
08:30-17:00 CC223 enhances cisplatin sensitivity of platinum-resistant ovarian cancer by inducing cell cycle arrest
Ling Wang (Chongqing University Cancer Hospital)
08:30-17:00 The oncology and fertility outcomes in patients with ovarian steroid cell tumors: a single center experience
Jiayuan Zhao (Peking Union Medical College Hospital)
08:30-17:00 Enhancing PARP inhibitor efficacy by targeting DNA repair and drug efflux to amplify the cGAS–STING pathway for chemotherapy-immunotherapy in ovarian cancer
Yi Sun (National Cancer Center)
08:30-17:00 A 25-year evolution in the diagnosis and treatment of malignant ovarian germ cell tumors: A single-center analysis of pathological subtypes, treatment modalities, and prognosis
Xinyue Zhang (Peking Union Medical College Hospital)
08:30-17:00 FOXA1 regulates tumor progression and immunotherapy response in ovarian cancer
Tae Wan Kim (Soonchunhyang University)
08:30-17:00 Rethinking neoadjuvant chemotherapy for ovarian cancer: Population-based evidence of worse survival
Jun-Hyeong Seo (Sungkyunkwan University)
08:30-17:00 Real-world safety and effectiveness of niraparib in adult patients with ovarian cancer: A post-marketing surveillance study in South Korea
Jeong-Yeol Park (Asan Medical Center)
08:30-17:00 Ascending paralysis revealing metastatic uterine sarcoma
Toni Marie Chavez (Adventist Medical Center)
08:30-17:00 Evaluation of methylated CDO1 and CELF4 as non-invasive biomarkers for endometrial cancer detection in postmenopausal women with bleeding symptoms
Bingxin Cai (Gansu Provincial Central Hospital)
08:30-17:00 CDO1/CELF4 methylation in cervical cells shows superior accuracy to TVS and serum biomarkers for endometrial cancer in women with abnormal uterine bleeding
Shen Zhang (Fujian Medical University)
08:30-17:00 Ultrastaging in sentinel lymph node assessment in endometrial carcinoma
Aticha Patinavin (Chulalongkorn University)
08:30-17:00 Predicting p53 mutation in endometrial cancer: Clinical correlates, prognosis, and preoperative modeling
Xinran Li (Peking Union Medical College Hospital)
08:30-17:00 Feasibility of Vaginal Swabs for Non-Invasive Diagnosis: Distinct DNA Methylation Landscapes in Endometrial Cancer
Yung-Taek Ouh (Korea University)
08:30-17:00 Multicenter Comparative Evaluation of Two MSI Detection Kits in Endometrial Cancer and Their Sensitivity at Low Tumor Fractions
Min Jin Jeong (The Catholic University of Korea)
08:30-17:00 Clinical utility of Droplex POLE for detection of clinically relevant POLE hotspot mutations in endometrial cancer
Seunghyeon Byeon (Gencurix Inc.)
08:30-17:00 Biomarker-based subclassification of no specific molecular profile endometrial cancer and its prognostic implications
Heekyoung Song (The Catholic University of Korea)
08:30-17:00 A rare case of lynch syndrome result from a mosaic pathogenic variant in MSH6 in endometrial cancer: A case report
Eun Hye Cho (Inje University)
08:30-17:00 Diethylstilbestrol-induced endometrial carcinogenesis through estrogen receptor α signaling: Evidence from an in vivo model
Setyo Teguh Waluyo (Universitas Airlangga)
08:30-17:00 Spatial proteomic profiling by CODEX reveals distinct immune landscapes in MMRd and p53‑aberrant endometrioid carcinoma of endometrium
Yi-Hsin Lin (Tri-Service General Hospital)
08:30-17:00 Establishment of a rabbit uterine cancer model using VX2 tumor fragments
Sohyeon Jeong (Korea University)
08:30-17:00 Lymphovascular space invasion as an independent prognostic factor in early-stage endometrial cancer
Anh Quang Nguyen (Vietnam National Cancer Hospital)
08:30-17:00 Molecular classification of endometrial carcinoma: The concordance between endometrial biopsy tissue and hysterectomy specimen
Wasawat Pattanachairuj (Chulalongkorn University)
08:30-17:00 Treatment outcomes and clinicopathological determinants in uterine carcinosarcoma: A 10-year retrospective study at Siriraj Hospital
Waraphon Thongsang (Mahidol University)
08:30-17:00 Comparative validation of the 2025 versus 2020 ESGO/ESTRO/ESP risk stratification systems in endometrial cancer: A 2010–2023 real-world cohort
Sohyeon Jeong (Korea University)
08:30-17:00 Real-world survival outcomes of first-line immune checkpoint inhibitor plus chemotherapy in advanced/recurrent endometrial cancer
Aeran Seol (Seoul National University)
08:30-17:00 Heterogeneity within aggressive endometrial carcinoma: A comparative study of high-grade endometrioid and serous subtypes with genetic profiling
Zhen Yuan (Peking Union Medical College Hospital)
08:30-17:00 Probability of coexisting leiomyosarcoma in surgically treated uterine leiomyomas initially considered benign
Khulkar Khurramova (Central Asian University)
08:30-17:00 Managing uterine adenosarcoma with surgical intervention alone - a rare case report
Riska Subono (Airlangga University)
08:30-17:00 Lenvatinib-induced palmoplantar erythrodysesthesia in recurrent endometrial cancer: A case report
Anh Nguyen Van Tuan (Hue Central Hospital)
08:30-17:00 Ureter stricture after laparoscopic radical hysterectomy
kyongjin kim (Presbyterian Medical Center)
08:30-17:00 ANO1: A novel therapeutic target for mediating progesterone resistance and tumor progression in endometrial cancer
Jianliu Wang (Peking University People’s Hospital)
08:30-17:00 Rethinking the bokhman classification: Uterine serous carcinoma is estrogen-dependent
Xuerun Liu (Peking University People's Hospital)
08:30-17:00 Does microsatellite instability (MSI) status in recurrent endometrial cancer influence prognosis?
Jun Takeuchi (Yokohama City Western Hospital)
08:30-17:00 Fertility-sparing treatment in endometrial cancer: The role of molecular classification beyond traditional selection criteria - a systematic review and meta-analysis
Abeer Alatawi (Korea University)
08:30-17:00 Surgical outcomes of laparoscopy versus laparotomy for endometrial cancer: Experience from a single tertiary referral center in Indonesia
Febia Erfiandi (Universitas Padjadjaran)
08:30-17:00 Selective omission management in POLE-mutated endometrial carcinoma (SiMPLE)
Seongmin Kim (Korea University)
08:30-17:00 Proteomic profiling reveals molecular differences between usual-type and gastric-type endocervical adenocarcinoma
Yili Chen (The First Affiliated Hospital of Sun Yat-sen University)
08:30-17:00 Geospatial Analysis of Air Pollution Exposure and Cervical Cancer Screening Trends in Indonesia: A GWR Approach Using Multi-Sensor Satellite Data (2018–2025)
Jeddah Yanti (Gadjah Mada University)
08:30-17:00 Feasibility and safety of autologous peripheral blood stem cell transplantation for hematopoietic reconstruction in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy: A prospective case series
Na Zhang (Chongqing University Cancer Hospital)
08:30-17:00 Biopsychosocial determinants of cortisol levels in cervical cancer patients: The roles of spirituality, anxiety, and depression during chemotherapy
Virigiawan Listanto (Hasanuddin University)
08:30-17:00 Preventable risk attribution of cervical cancer mortality in Indonesia: A population-level analysis using global burden of disease data
Zavia Putri Salsabila (Universitas Islam Indonesia)
08:30-17:00 Neoadjuvant chemotherapy drives stable basement membrane–anchored structural reprogramming that promotes invasive behavior in cervical neuroendocrine carcinoma
Zhen Zheng (Peking Union Medical College Hospital)
08:30-17:00 Establishing a rare cervical cancer organoid biobank and defining therapeutic vulnerabilities in neuroendocrine cervical carcinoma through integrated multi-omics
Yishan Jin (Peking Union Medical College Hospital)
08:30-17:00 Higher expression of circulating plasma miR-10a predicts pelvic lymph node metastasis and poor response to radiation therapy in patient with cervical cancer
Pande Kadek Aditya Prayudi (Hasan Sadikin Hospital)
08:30-17:00 Impact of prior lymphadenectomy on immunotherapy efficacy in recurrent cervical cancer
Hao He (Chongqing University Cancer Hospital)
08:30-17:00 Prognostic factors and survival outcomes among women aged 65 years and older: A national study
Hui-Shan Liu (Fu Jen Catholic University Hospital)
08:30-17:00 Reproductive outcome of radical abdominal trachelectomy: A case report
Amarsanaa Enkhtur (National Cancer Center of Mongolia)
08:30-17:00 Pelvic lymph node size and outcomes in FIGO 2018 stage IIIC1 cervical cancer with resectable primary tumor
Atsushi Fusegi (Cancer Institute Hospital of JFCR)
08:30-17:00 NSUN4 suppresses ferroptosis through m5C-dependent stabilization of C-MYC and activation of the PI3K/Akt signaling pathway in cervical cancer
Tian Duancheng (Peking Union Medical College Hospital)
08:30-17:00 Impact of rectal gas evacuation on dosimetry and applicator displacement in cervical cancer brachytherapy
Haiyan Wu (Chongqing University Cancer Hospital)
08:30-17:00 Evaluation of individualized three-dimensional brachytherapy strategies based on high-risk clinical target volume maximum cross-sectional area: A single-center retrospective study
Chengdian He (Chongqing University Cancer Hospital)
08:30-17:00 Efficacy and safety of different sequences of deep hyperthermia combined with chemoradiotherapy for locally advanced cervical cancer: A prospective randomized controlled study
Na Zhang (Chongqing University Cancer Hospital)
08:30-17:00 Primary–metastasis paired spatial transcriptomics defines organ-specific microenvironments in cervical cancer
Yu Zhang (Peking Union Medical College Hospital)
08:30-17:00 Refining the “no-look no-touch” technique in laparoscopic radical trachelectomy: A 10-year experience of oncologic and obstetric outcomes
Risako Ozawa (Cancer Institute Hospital of JFCR)
08:30-17:00 Swede Score Versus 2017 ASCCP Colposcopic Terminology for Prediction of High-Grade Cervical Lesion in Patients with Abnormal Cervical Cancer Screening
Chanokrak Sriwattanapong (Thammasat University Hospital)
08:30-17:00 Preventive effect of HPV vaccination in women treated for CIN3+: A retrospective Korean cohort study
Sanha Lee (The Catholic University of Korea)
08:30-17:00 A retrospective study: Outcomes of paiteling in women with cervical intraepithelial neoplasia and persistent HR-HPV infection
Yimin Cong (Zhongke Kangbo Clinic)
08:30-17:00 Clinical significance of endocervical versus exocervical margin involvement in two-step LEEP conization
In Sun Hwang (The Catholic University of Korea)
08:30-17:00 Risk of persistent abnormal cytology according to surgeon preference for colpotomy mode in type a hysterectomy for cervical intraepithelial neoplasia and early-stage cervical cancer
Taehun Kim (SMG-SNU Boramae Medical Center)
08:30-17:00 An unwanted transition: Endometrial carcinoma in a 37-year-old transgender male on gender-affirming hormone therapy
Marianell Basunillo (Brokenshire Medical Center)
08:30-17:00 Surgical treatment of a 25 cm uterine leiomyoma with lung metastasis: A case report
Tumarisi Tuniyazi (Dalian University of Technology)
08:30-17:00 Severe anemia as an early warning sign of gestational trophoblastic neoplasia progression: Diagnostic pitfalls of rising β-hCG despite repeated curettage
Putri Nadya Syahidah (Padjadjaran University)
08:30-17:00 Aggressive angiomyxoma of the vulva mimicking malignancy: A case report
Mona Nulanda (Airlangga University)
08:30-17:00 When a common tumor appears in an uncommon site: Diagnostic challenges of vulvar leiomyoma a rare case report
Ivan Albert Bunjamin (Universitas Padjadjaran)
08:30-17:00 Extramammary paget’s disease of the vulva mimicking other skin diseases - a diagnostic challenge of the rare case report
Niswan Helja (Universitas Padjadjaran)
08:30-17:00 A decade-long latency and diagnostic challenge: STR analysis provides definitive closure in a case of postmenopausal gestational choriocarcinoma
Taisheng Zheng (Zhangzhou Hospital)
08:30-17:00 Rare vulvar mesenchymal tumors mimicking benign vulvar lesions: A case series
Su Min Sohn (Korea University)
08:30-17:00 Incidence of cancer of extra-cervical origins in women with atypical glandular cell (AGC) on cervical cytology screening
Achiraya Rattanapan (Vajira Hospital)
08:30-17:00 Advanced squamous cell carcinoma of the tongue with parotid and cervical nodal metastases
Ynjindulam Otgon (Health Center of Bayanzurkh disctrict)
08:30-17:00 Neonatal renal neuroblastoma
Maralmaa Demchigsuren (Health Center of Bayanzurkh disctrict)
08:30-17:00 Knowledge of gestational diabetes mellitus among pregnant women in a tertiary hospital in Marawi City Lanao del Sur
Al-jazarie Masacal (Amaipakpak Medical Center)
08:30-17:00 Launching a regional platform for early-career gynecologic oncologists in Asia: The establishment of ASYGO
Miseon Nakazawa (Sapporo Medical University)
08:30-17:00 High grade dermatofibrosarcoma protuberans arising from a Pfannenstiel incision
Min Kyung Kwak (Korea University)
08:30-17:00 Changes in BMD after radiotherapy in cervical cancer and endometrial cancer
In Sun Hwang (The Catholic University of Korea)
08:30-17:00 Diagnostic challenges of tubo-ovarian abscess mimicking malignancy: Discrepancy between preoperative suspicion and intraoperative findings
Intan Solihat Samsudin (Universitas Padjadjaran)
08:30-17:00 Association between obesity and gynecologic cancer in the elderly population: A nationwide population-based cohort study
Min Chul Choi (Asan Medical Center)
08:30-17:00 Venous thromboembolism before treatment initiation predicts poorer survival in gynecologic cancers
Kaoru Fujieda (University of Tsukuba)
08:30-17:00 High frequency of p53 abnormalities in early-stage, low-grade endometrioid endometrial cancer: A case series and systematic review
Yuriko Wada (Indonesia Army Hospital)
08:30-17:00 Trastuzumab and taxane combination therapy in HER2+ metastatic extramammary Paget’s disease of vulva
Yoon-Jung Jung (Hallym University)
08:30-17:00 Complete expulsion of a hydatidiform mole following vaginal misoprostol: Insights from an unintended treatment – a case report
Hyung Joon Yoon (Pusan National University)
08:30-17:00 ERAS implementation in gynecologic oncology: A mixed-methods study on adherence, outcomes, and healthcare professional’ perspectives
Henny Meitri Andrie Rachmasari Putri (Indonesia Army Hospital)
Program
April 3 (Fri)
08:30-17:00
Surgical Film Screening
Exhibition
08:30-17:00 Minimally invasive fertility preservation: Robot-assisted vNOTES trachelectomy
In Sun Hwang (The Catholic University of Korea)
08:30-17:00 Robotic posterior pelvic exenteration with anus preservation for primary vaginal cancer stage IVA: Case report
Mais AlHulwah (The Catholic University of Korea)
08:30-17:00 PALND in uterine carcinoma
Alaa Metwally (Severance Hospital)